LifeVantage Co. (NASDAQ:LFVN – Get Rating) declared a quarterly dividend on Tuesday, August 23rd, Zacks reports. Shareholders of record on Friday, September 2nd will be paid a dividend of 0.03 per share on Thursday, September 15th. This represents a $0.12 dividend on an annualized basis and a yield of 3.18%. The ex-dividend date is Thursday, September 1st.

LifeVantage has a payout ratio of 21.8% indicating that its dividend is sufficiently covered by earnings.

LifeVantage Price Performance

Shares of NASDAQ LFVN opened at $3.77 on Wednesday. The firm has a market capitalization of $47.31 million, a P/E ratio of 15.71 and a beta of 1.21. The stock's 50-day simple moving average is $4.25 and its two-hundred day simple moving average is $4.51. LifeVantage has a twelve month low of $3.71 and a twelve month high of $8.02.

Wall Street Analyst Weigh In

Institutional Investors Weigh In On LifeVantage

Institutional investors have recently bought and sold shares of the stock. American Century Companies Inc. boosted its holdings in LifeVantage by 30.3% during the 1st quarter. American Century Companies Inc. now owns 46,016 shares of the company's stock valued at $219,000 after acquiring an additional 10,706 shares during the period. State Street Corp boosted its holdings in LifeVantage by 7.6% during the 1st quarter. State Street Corp now owns 46,191 shares of the company's stock valued at $220,000 after acquiring an additional 3,281 shares during the period. EP Wealth Advisors LLC purchased a new stake in LifeVantage during the 1st quarter valued at about $234,000. BlackRock Inc. boosted its holdings in LifeVantage by 10.5% during the 1st quarter. BlackRock Inc. now owns 249,547 shares of the company's stock valued at $1,188,000 after acquiring an additional 23,788 shares during the period. Finally, Dimensional Fund Advisors LP boosted its holdings in LifeVantage by 4.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 271,614 shares of the company's stock valued at $1,293,000 after acquiring an additional 11,964 shares during the period. 27.06% of the stock is currently owned by hedge funds and other institutional investors.

About LifeVantage

(Get Rating)

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes.

Featured Stories

• Get a free copy of the StockNews.com research report on LifeVantage (LFVN)
• Can Pinterest Rally On Support From Big Investor With Conviction?
• Chargepoint Rallies, Despite Weaker Earnings
• Is Cadence Close To A Cup-With-High-Handle Breakout?
• How the Pandemic Forced F5 to Flex its Software Side
• Shock Absorbers: 3 Low Volatility Dividend Stocks for Bumpy Times

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.